Patients who achieved HIV virologic suppression tended to be older and were more likely to report continued engagement in HIV care than those with persistent viremia.

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

In contrast to the global decline in HIV infections and deaths, Bangladesh is witnessing a troubling rise in both cases and ...

A vaccine to prevent HIV infection, the virus that leads to AIDS, has shown modest results for the first time, researchers have found, raising hopes that a disease that kills millions every year may ...

In contrast to the global decline in HIV infections and deaths, Bangladesh is witnessing a troubling rise in both cases and ...

Learn about the unique health and social needs of HIV-infected senior Americans. Health experts emphasize the importance of prevention, testing, and care.

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage - NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections ...

A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

Lenacapavir has delivered impressive trial results and, in July, it received official backing from the World Health ...

Pharma major Lupin Ltd on Wednesday said it has received tentative approval from the US health regulator for its generic ...

Scientists have long studied how Zika virus harms the developing brain, but until now, its effects on the adult brain were less clear ...

Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 (around R692) per person per ...